Literature DB >> 29353900

Prevalence of Tuberculosis in Patients with Liver Cirrhosis.

Dilip Sharma1, Sudhamshu Kc1, Bikash Jaisi1.   

Abstract

BACKGROUND: Studies have shown that patients with liver cirrhosis are more susceptible to tuberculosis because of immune dysfunction; however there are only limited data. We carried out this study to know the prevalence and clinical characteristics of tuberculosis in patients with liver cirrhosis.
METHODS: In this retrospective study, medical files of 200 consecutive patients admitted with diagnosis of liver cirrhosis in the medical ward of liver unit, Bir Hospital from January 2011 to December 2014 were evaluated for the presence of TB and clinical characteristics of these patients were analyzed.
RESULTS: Eighteen patients were diagnosed to have tuberculosis with a prevalence of 9%. The median age of patients with tuberculosis and liver cirrhosis was 53 (35-71) years and M: F ratio was 2:1. 67%, P=0.01). Median CTP score of patients were 8.5 (5-12) (CTP A: B: C: 3:7:8). Extra pulmonary tuberculosis was more common (67%) than pulmonary (33%). In extra pulmonary tuberculosis, distribution was as pleural effusion (n=4), abdominal (n=4), intestinal (n=2), peritoneal (n=9), and pott's spine (n=2).
CONCLUSIONS: Tuberculosis is prevalent in patients with liver cirrhosis. Extra pulmonary tuberculosis was more compared to pulmonary tuberculosis. Tuberculosis was common in decompensated liver cirrhosis than compensated liver cirrhosis .

Entities:  

Keywords:  Cirrhosis; extra pulmonary; pulmonary; tuberculosis.

Mesh:

Year:  2018        PMID: 29353900     DOI: 10.3126/jnhrc.v15i3.18852

Source DB:  PubMed          Journal:  J Nepal Health Res Counc        ISSN: 1727-5482


  1 in total

1.  Hepatomusculoskeletal disorders: Coining a new term might improve the management of the musculoskeletal manifestations of chronic liver disease.

Authors:  Christos Tsagkaris; Stavros P Papadakos; Dimitrios V Moysidis; Andreas S Papazoglou; Alexandra Koutsogianni; Marios Papadakis
Journal:  World J Gastrointest Pathophysiol       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.